646 related articles for article (PubMed ID: 2983062)
1. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies.
Hillard CJ; Harris RA; Bloom AS
J Pharmacol Exp Ther; 1985 Mar; 232(3):579-88. PubMed ID: 2983062
[TBL] [Abstract][Full Text] [Related]
2. Studies of the role of membrane lipid order in the effects of delta 9-tetrahydrocannabinol on adenylate cyclase activation in heart.
Hillard CJ; Pounds JJ; Boyer DR; Bloom AS
J Pharmacol Exp Ther; 1990 Mar; 252(3):1075-82. PubMed ID: 2156989
[TBL] [Abstract][Full Text] [Related]
3. Effects of barbiturates and ethanol on the physical properties of brain membranes.
Harris RA; Schroeder F
J Pharmacol Exp Ther; 1982 Nov; 223(2):424-31. PubMed ID: 7131297
[TBL] [Abstract][Full Text] [Related]
4. Physical properties and lipid composition of brain membranes from ethanol tolerant-dependent mice.
Harris RA; Baxter DM; Mitchell MA; Hitzemann RJ
Mol Pharmacol; 1984 May; 25(3):401-9. PubMed ID: 6539418
[TBL] [Abstract][Full Text] [Related]
5. Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain.
Tripathi HL; Vocci FJ; Brase DA; Dewey WL
Alcohol Drug Res; 1987; 7(5-6):525-32. PubMed ID: 3620017
[TBL] [Abstract][Full Text] [Related]
6. Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents.
Shook JE; Burks TF
J Pharmacol Exp Ther; 1989 May; 249(2):444-9. PubMed ID: 2542532
[TBL] [Abstract][Full Text] [Related]
7. Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices.
Reichman M; Nen W; Hokin LE
Mol Pharmacol; 1988 Dec; 34(6):823-8. PubMed ID: 2849049
[TBL] [Abstract][Full Text] [Related]
8. Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus.
Lindamood C; Colasanti BK
J Pharmacol Exp Ther; 1980 May; 213(2):216-21. PubMed ID: 6245205
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats.
Zuardi AW; Teixeira NA; Karniol IC
Arch Int Pharmacodyn Ther; 1984 May; 269(1):12-9. PubMed ID: 6087750
[TBL] [Abstract][Full Text] [Related]
10. Developmental changes in synaptic membrane fluidity: a comparison of 1,6-diphenyl-1,3,5-hexatriene (DPH) and 1-[4-(trimethylamino)phenyl]-6-phenyl-1,3,5-hexatriene (TMA-DPH).
Hitzemann RJ; Harris RA
Brain Res; 1984 May; 316(1):113-20. PubMed ID: 6733531
[TBL] [Abstract][Full Text] [Related]
11. Delta9-THC as a discriminative cue in pigeons: effects of delta8-THC, CBD, and CBN.
Järbe TU; Henriksson BG; Ohlin GC
Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):68-72. PubMed ID: 921403
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid-like effects of aminoalkylindole compounds on the physical properties of brain membranes: fluorescence polarization studies.
Moldovan JC; Ward SJ; Bloom AS
NIDA Res Monogr; 1990; 105():302-3. PubMed ID: 1876019
[No Abstract] [Full Text] [Related]
13. Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes.
Poddar MK; Dewey WL
J Pharmacol Exp Ther; 1980 Jul; 214(1):63-7. PubMed ID: 7391971
[TBL] [Abstract][Full Text] [Related]
14. Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.
Moldzio R; Pacher T; Krewenka C; Kranner B; Novak J; Duvigneau JC; Rausch WD
Phytomedicine; 2012 Jun; 19(8-9):819-24. PubMed ID: 22571976
[TBL] [Abstract][Full Text] [Related]
15. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; Gefroh HA; Devane CL
J Pharmacol Exp Ther; 2006 May; 317(2):850-7. PubMed ID: 16439618
[TBL] [Abstract][Full Text] [Related]
16. A conformational model for the action of general anesthetics at the membrane level. II. Experimental observations on the effects of anesthetics on lipid fluidity and lipid protein interactions.
Lenaz G; Mazzanti L; Curatola G; Bertoli E; Bigi A; Zolese G
Ital J Biochem; 1978; 27(6):401-30. PubMed ID: 755801
[TBL] [Abstract][Full Text] [Related]
17. Modulation of rat brain opioid receptors by cannabinoids.
Vaysse PJ; Gardner EL; Zukin RS
J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
[TBL] [Abstract][Full Text] [Related]
18. Membrane disordering by anesthetic drugs: relationship to synaptosomal sodium and calcium fluxes.
Harris RA; Bruno P
J Neurochem; 1985 Apr; 44(4):1274-81. PubMed ID: 2579208
[TBL] [Abstract][Full Text] [Related]
19. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
Bornheim LM; Kim KY; Li J; Perotti BY; Benet LZ
Drug Metab Dispos; 1995 Aug; 23(8):825-31. PubMed ID: 7493549
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of the stimulus produced by the mixture of cannabidiol with delta 9-tetrahydrocannabinol.
Zuardi AW; Finkelfarb E; Bueno OF; Musty RE; Karniol IG
Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):137-46. PubMed ID: 6261703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
